Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

The live webcast, which will include presentation slides, may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 60 ...

Corvus Robotics Appoints Michael McSpedon as Chief Revenue Officer to Accelerate US Growth and Enterprise Adoption

Corvus Robotics , a leader in deploying physical AI robotic systems for logistics and warehousing operations, today announced ...
American Association of Individual Investors

Why Corvus Pharmaceuticals, Inc.’s (CRVS) Stock Is Down 6.45%

As of Thursday, January 08, Corvus Pharmaceuticals, Inc.’s CRVS share price has dipped by 6.45%, which has investors ...
Hosted on MSN

Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased

Shares of Corvus Pharmaceuticals, Inc. (CRVS) traded 30% higher on Friday afternoon after Oppenheimer raised its price target on the stock to $17 from $15, while keeping an ‘Outperform’ rating on the ...

Retail investors account for 39% of Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) ownership, while institutions account for 39%

Every investor in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the ...
Yahoo Finance

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data from the ...
ZDNet

Corvus Insurance raises $100 million, aims to broaden business, cyber insurance reach, AI platform

The cyber insurance industry is likely to go mainstream and is a simple cost of doing business. Here are a few options to consider. Read now Corvus Insurance, a company focused on applying artificial ...
Business Wire

Corvus and Core Specialty to Deliver Expansion of AI-Powered Excess Tech E&O and Cyber Product

BOSTON--(BUSINESS WIRE)--Corvus Insurance, the leading cyber underwriter, powered by a proprietary AI-driven cyber risk platform, announced today the launch of a new program with Core Specialty to ...
TwinCities.com

Sky Watch: Corvus the Crow isn’t much of a constellation, but it has a great story

In my other life I’ve been a weather forecaster for nearly 40 years, and admittedly when the forecast goes really bad I end up eating crow! Why is it that crows get such a bad rap? They’re actually ...
The Bookseller

Corvus appoints Stephanie Carey as editorial director

Carey said: "I am delighted to join Corvus after a fantastic 18 months at Embla. It’s an incredibly exciting time for Atlantic and I can’t wait to work with the fantastic team to find and publish more ...
TMCnet

Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...